On June 2, 2022, Aimed Alliance released a new fact sheet on biomarker testing titled “Increase Access to Precision Medicine for Patients with Cancer Through Biomarker Testing.” This new fact sheet reviews the benefits of biomarker testing for patients with cancer and the current limitations to receiving biomarker testing as a result of limited health plan coverage and burdensome prior authorization policies. The new fact sheet can be found here.
Last Updated on June 2, 2022 by Aimed Alliance
